TG Therapeutics Inc (FRA:NKB2)
€ 33.42 +0.32 (+0.95%) Market Cap: 5.18 Bil Enterprise Value: 5.07 Bil PE Ratio: 157.96 PB Ratio: 25.27 GF Score: 76/100

TG Therapeutics Inc (FRA:NKB2) Transcripts

  • 1